Literature DB >> 17143272

Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism.

Wing-Yu Fu1, Yu Chen, Mustafa Sahin, Xiao-Su Zhao, Lei Shi, Jay B Bikoff, Kwok-On Lai, Wing-Ho Yung, Amy K Y Fu, Michael E Greenberg, Nancy Y Ip.   

Abstract

The development of dendritic spines is thought to be crucial for synaptic plasticity. Dendritic spines are retracted upon Eph receptor A4 (EphA4) activation, but the mechanisms that control this process are not well understood. Here we report an important function of cyclin-dependent kinase 5 (Cdk5) in EphA4-dependent spine retraction in mice. We found that blocking Cdk5 activity inhibits ephrin-A1-triggered spine retraction and reduction of mEPSC frequency at hippocampal synapses. The activation of EphA4 resulted in the recruitment of Cdk5 to EphA4, leading to the tyrosine phosphorylation and activation of Cdk5. EphA4 and Cdk5 then enhanced the activation of ephexin1, a guanine-nucleotide exchange factor that regulates activation of the small Rho GTPase RhoA. The association between EphA4 and ephexin1 was significantly reduced in Cdk5(-/-) brains and Cdk5-dependent phosphorylation of ephexin1 was required for the ephrin-A1-mediated regulation of spine density. These findings suggest that ephrin-A1 promotes EphA4-dependent spine retraction through the activation of Cdk5 and ephexin1, which in turn modulates actin cytoskeletal dynamics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143272     DOI: 10.1038/nn1811

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  149 in total

Review 1.  Looking forward to EphB signaling in synapses.

Authors:  Slawomir Sloniowski; Iryna M Ethell
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

2.  CDK5 interacts with Slo and affects its surface expression and kinetics through direct phosphorylation.

Authors:  Jun-Ping Bai; Alexei Surguchev; Powrnima Joshi; Liza Gross; Dhasakumar Navaratnam
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-16       Impact factor: 4.249

Review 3.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

Review 4.  Guidance molecules in synapse formation and plasticity.

Authors:  Kang Shen; Christopher W Cowan
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-10       Impact factor: 10.005

5.  APC(Cdh1) mediates EphA4-dependent downregulation of AMPA receptors in homeostatic plasticity.

Authors:  Amy K Y Fu; Kwok-Wang Hung; Wing-Yu Fu; Chong Shen; Yu Chen; Jun Xia; Kwok-On Lai; Nancy Y Ip
Journal:  Nat Neurosci       Date:  2010-12-26       Impact factor: 24.884

6.  EphA signaling promotes actin-based dendritic spine remodeling through slingshot phosphatase.

Authors:  Lei Zhou; Emma V Jones; Keith K Murai
Journal:  J Biol Chem       Date:  2012-01-26       Impact factor: 5.157

7.  Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease.

Authors:  Alan S L Wong; Rebecca H K Lee; Anthony Y Cheung; Patrick K Yeung; Sookja K Chung; Zelda H Cheung; Nancy Y Ip
Journal:  Nat Cell Biol       Date:  2011-04-17       Impact factor: 28.824

8.  The neuronal p35 activator of Cdk5 is a novel F-actin binding and bundling protein.

Authors:  Lisheng He; Zhaojun Zhang; Yan Yu; Sohail Ahmed; Nam Sang Cheung; Robert Z Qi
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

9.  A subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5.

Authors:  Xin Yue; Cheryl Dreyfus; Tony Ah-Ng Kong; Renping Zhou
Journal:  Dev Neurobiol       Date:  2008-09-01       Impact factor: 3.964

Review 10.  Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.

Authors:  Levi M Smith; Stephen M Strittmatter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.